Dietary Polyphenols Curcumin and Resveratrol Exert Selective Anticancer Effects in Melanoma Cells

Background/Objectives: Although curcumin (CUR) and resveratrol (RSV) are natural polyphenolic compounds with reported anticancer and anti-inflammatory properties, their combined anticancer effects in melanoma cells remain incompletely characterized. This study aimed to evaluate the anticancer efficacy of CUR and RSV, individually, and in combination, in melanoma cells compared to normal melanocytes. Methods: Cell viability and intracellular ATP levels were quantified, and dose–response analyses performed. Cellular morphology and nuclear alterations were examined by phase-contrast microscopy and DAPI staining. Cell cycle distribution and apoptosis were analyzed by Muse™ Cell Analyzer with dedicated assay kits. Survival- and death-related signaling proteins were evaluated by Western blotting. Results: Combined treatment with CUR (60 μM) and RSV (40 μM) for 48 h synergistically reduced melanoma cell viability and markedly depleted intracellular ATP levels, while exerting minimal cytotoxic effects on normal melanocytes. CUR/RSV co-treatment induced pronounced morphological and nuclear alterations, significantly increased apoptotic cell populations, and modulated key signaling pathways regulating cell survival and programmed cell death in melanoma cells. Conclusions: These findings demonstrate that combined CUR and RSV treatment exerts enhanced, melanoma-selective anticancer activity while sparing normal melanocytes. The results provide a strong experimental rationale for further in vivo validation of CUR/RSV-based combination strategies as a potential therapeutic approach for melanoma.

• Publication year

  2026

• Venue

  Nutrients

• Publication date

  2026-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/nu18030548PMID 41683370PMCID 12899543
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Natural products as therapeutics for malignant melanoma: preclinical evidence and mechanism

  2025cited by this paper
• Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?

  2023cited by this paper
• Cancer statistics, 2023

  2023cited by this paper
• Effects of Resveratrol on Mouse B16 Melanoma Cell Proliferation through the SHCBP1-ERK1/2 Signaling Pathway

  2023cited by this paper
• Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis

  2023cited by this paper
• Targeting inflammasome pathway by polyphenols as a strategy for pancreatitis, gastrointestinal and liver diseases management: an updated review

  2023cited by this paper
• Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review

  2022cited by this paper
• Hallmarks of Cancer: New Dimensions.

  2022cited by this paper
• Evaluation of synergism in drug combinations and reference models for future orientations in oncology

  2022influential reference
• Targeting PI3K/Akt signal transduction for cancer therapy

  2021influential reference
• Resistance to Molecularly Targeted Therapies in Melanoma

  2021influential reference
• Novel Curcumin-Resveratrol Solid Nanoparticles Synergistically Inhibit Proliferation of Melanoma Cells

  2021cited by this paper
• A decade of immune-checkpoint inhibitors in cancer therapy

  2020cited by this paper
• Melanoma Metabolism: Cell Survival and Resistance to Therapy.

  2020influential reference
• Targeting the ERK Signaling Pathway in Melanoma

  2019cited by this paper
• Resveratrol induces apoptosis in human melanoma cell through negatively regulating Erk/PKM2/Bcl-2 axis

  2018cited by this paper
• Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

  2018cited by this paper
• Bidirectional interactions between dietary curcumin and gut microbiota

  2018cited by this paper
• Melanoma

  2018cited by this paper
• Initiation and execution mechanisms of necroptosis: an overview

  2017cited by this paper
• Dying cells actively regulate adaptive immune responses

  2017cited by this paper
• Necroptosis and Inflammation.

  2016cited by this paper
• Biological and therapeutic activities, and anticancer properties of curcumin.

  2015cited by this paper
• Resveratrol inhibits the proliferation of human melanoma cells by inducing G1/S cell cycle arrest and apoptosis.

  2015cited by this paper
• The future of immune checkpoint therapy

  2015cited by this paper
• Regulated necrosis: the expanding network of non-apoptotic cell death pathways

  2014cited by this paper
• The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes.

  2014cited by this paper
• Curcumin induces apoptosis through mitochondrial pathway and caspases activation in human melanoma cells

  2014cited by this paper
• Visible Light Is a Better Co-Inducer of Apoptosis for Curcumin-Treated Human Melanoma Cells than UVA

  2013cited by this paper
• Synergistic anti-cancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells.

  2013cited by this paper
• Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma

  2011cited by this paper
• Drug combination studies and their synergy quantification using the Chou-Talalay method.

  2010influential reference
• Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines

  2009cited by this paper
• Synergy research: approaching a new generation of phytopharmaceuticals.

  2009cited by this paper
• Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells.

  2008cited by this paper
• MAP kinase signalling pathways in cancer

  2007cited by this paper
• Resveratrol: a review of preclinical studies for human cancer prevention.

  2007cited by this paper
• Bioavailability of curcumin: problems and promises.

  2007cited by this paper
• In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide

  2004cited by this paper
• Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.

  2004cited by this paper
• Resveratrol is a potent inducer of apoptosis in human melanoma cells.

  2003cited by this paper
• Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53.

  2001cited by this paper
• Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes

  1997cited by this paper

• No citing papers are available for this paper.